EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
  • Query in any language with multilingual search
  • Access EUR-Lex and EU Commission case law
  • See relevant paragraphs highlighted instantly
Start free trial

Similar Documents

Explore similar documents to your case.

We Found Similar Cases for You

Sign up for free to view them and see the most relevant paragraphs highlighted.

Case C-601/24, Gotka: Request for a preliminary ruling from the Sąd Rejonowy w Jarosławiu (Poland) lodged on 16 September 2024 – V.B.

ECLI:EU:UNKNOWN:62024CN0601

62024CN0601

September 16, 2024
With Google you find a lot.
With us you find everything. Try it now!

I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!

Valentina R., lawyer

Official Journal of the European Union

EN

C series

C/2025/138

13.1.2025

(Case C-601/24, Gotka)

(C/2025/138)

Language of the case: Polish

Referring court

Parties to the main proceedings

Defendant: V.B.

Other party: Prokurator Prokuratury Rejonowej w Jarosławiu

Questions referred

1.Must the term ‘specimen’ as used in Article 2(t) of Council Regulation (EC) No 338/97 of 9 December 1996 on the protection of species of wild fauna and flora by regulating trade therein be interpreted as encompassing a medicinal product which is legally available in pharmacies of a third country that is not a member of the European Union and which contains, in its complex composition, inter alia, extract of Japanese seahorse (Syngnathidae Hippocampus spp. (II)), listed in Annex B to that regulation?

2.Must Article 1 of Council Regulation (EC) No 338/97 of 9 December 1996 on the protection of species of wild fauna and flora by regulating trade therein, read in the light of Article 2(t) of that regulation, be interpreted as precluding rules of national law according to which it is possible to hold criminally responsible a consumer who imports into the Community (without a permit) a medicinal product for personal use which was legally purchased in a pharmacy of a third country that is not a member of the European Union and which contains, in its complex composition, inter alia, extract of Japanese seahorse (Syngnathidae Hippocampus spp. (II)), listed in Annex B to that regulation, if there is no evidence of a commercial purpose?

3.Must the term ‘personal or household effects’ as used in Article 2(j) of Council Regulation (EC) No 338/97 of 9 December 1996 on the protection of species of wild fauna and flora by regulating trade therein, which serves as the basis for an exemption (derogation) from the obligation to present a permit under Article 7(3) of that regulation, be interpreted as encompassing a medicinal product which is acquired for the medical needs of the purchaser or of a close relative, was legally purchased in a pharmacy of a third country that is not a member of the European Union, and contains, in its complex composition, inter alia, extract of Japanese seahorse (Syngnathidae Hippocampus spp. (II)), listed in Annex B to that regulation, if there is no evidence of a commercial purpose?

The name of the present case is a fictitious name. It does not correspond to the real name of any party to the proceedings.

OJ 1997 L 61, p. 1.

ELI: http://data.europa.eu/eli/C/2025/138/oj

ISSN 1977-091X (electronic edition)

EurLex Case Law

AI-Powered Case Law Search

Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly

Get Instant Answers to Your Legal Questions

Cancel your subscription anytime, no questions asked.Start 14-Day Free Trial

At Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.

Contact Us

Tivolska cesta 48, 1000 Ljubljana, Slovenia